Bionpharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIONPHARMA, and when can generic versions of BIONPHARMA drugs launch?
BIONPHARMA has seventy approved drugs.
There are five US patents protecting BIONPHARMA drugs.
There are ten patent family members on BIONPHARMA drugs in thirteen countries and one hundred and twenty-one supplementary protection certificates in fifteen countries.
Summary for Bionpharma
International Patents: | 10 |
US Patents: | 5 |
Tradenames: | 65 |
Ingredients: | 60 |
NDAs: | 70 |
Patent Litigation for Bionpharma: | See patent lawsuits for Bionpharma |
Drugs and US Patents for Bionpharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bionpharma | BENZONATATE | benzonatate | CAPSULE;ORAL | 081297-002 | Oct 30, 2007 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Bionpharma | CLOBAZAM | clobazam | TABLET;ORAL | 208825-002 | Oct 22, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Bionpharma | DROXIDOPA | droxidopa | CAPSULE;ORAL | 213033-003 | Apr 28, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Bionpharma | VITAMIN D | ergocalciferol | CAPSULE;ORAL | 080704-001 | Approved Prior to Jan 1, 1982 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Bionpharma | ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077813-002 | Aug 16, 2006 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bionpharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bionpharma | MIDOL LIQUID GELS | ibuprofen | CAPSULE;ORAL | 021472-001 | Oct 18, 2002 | 6,251,426 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Bionpharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Denmark | 1863458 | ⤷ Subscribe |
Spain | 2606767 | ⤷ Subscribe |
European Patent Office | 3061447 | ⤷ Subscribe |
Slovenia | 1863458 | ⤷ Subscribe |
China | 101166520 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bionpharma Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0245997 | C300002 | Netherlands | ⤷ Subscribe | PRODUCT NAME: DOFETILIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/99/121/001 - EU/1/99/121/015 19991129 |
0994863 | 07C0037 | France | ⤷ Subscribe | PRODUCT NAME: MODIFICATION CRISTALLINE A DU RUFINAMIDE; REGISTRATION NO/DATE IN FRANCE: EU/1/06/378/001 DU 20070116; REGISTRATION NO/DATE AT EEC: EU/1/06/378/001-016 DU 20070116 |
0914118 | SPC/GB07/002 | United Kingdom | ⤷ Subscribe | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB07/002 GRANTED TO NOVARTIS AG IN RESPECT OF THE PRODUCT DEFERASIROX AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, ESPECIALLY 4-(3,5-BIS(2-HYDROXYPHENYL)-(1,2,4) TRIAZOL-L-YL) BENZOIC ACID, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6179 DATED 24 OCTOBER 2007 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 30 AUGUST 2021. |
1427415 | 11C0042 | France | ⤷ Subscribe | PRODUCT NAME: APIXABAN, EVENTUELLEMENT SOUS LA FORME D'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/11/691/001 20110520 |
1427415 | SPC/GB11/042 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: APIXABAN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/11/691/001 20110520; UK EU/1/11/691/002 20110520; UK EU/1/11/691/003 20110520; UK EU/1/11/691/004 20110520; UK EU/1/11/691/005 20110520 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.